1. Home
  2. TTEC vs UNCY Comparison

TTEC vs UNCY Comparison

Compare TTEC & UNCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TTEC Holdings Inc.

TTEC

TTEC Holdings Inc.

HOLD

Current Price

$2.36

Market Cap

128.5M

Sector

Technology

ML Signal

HOLD

Logo Unicycive Therapeutics Inc.

UNCY

Unicycive Therapeutics Inc.

HOLD

Current Price

$7.32

Market Cap

145.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TTEC
UNCY
Founded
1982
2016
Country
United States
United States
Employees
69400
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
128.5M
145.3M
IPO Year
1996
2021

Fundamental Metrics

Financial Performance
Metric
TTEC
UNCY
Price
$2.36
$7.32
Analyst Decision
Hold
Strong Buy
Analyst Count
2
3
Target Price
N/A
$25.67
AVG Volume (30 Days)
455.3K
765.0K
Earning Date
05-07-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
40.80
N/A
EPS
N/A
N/A
Revenue
$1,509,171,000.00
$675,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$0.10
$582.86
P/E Ratio
N/A
N/A
Revenue Growth
2.15
N/A
52 Week Low
$1.98
$3.72
52 Week High
$5.59
$8.74

Technical Indicators

Market Signals
Indicator
TTEC
UNCY
Relative Strength Index (RSI) 44.42 49.14
Support Level $2.12 $6.81
Resistance Level $2.74 $7.43
Average True Range (ATR) 0.17 0.58
MACD -0.02 0.00
Stochastic Oscillator 38.89 41.43

Price Performance

Historical Comparison
TTEC
UNCY

About TTEC TTEC Holdings Inc.

TTEC Holdings Inc provides customer engagement management tools and services. The company operates through two operating segment, TTEC Digital and TTEC Engage. TTEC Digital is engaged in building and implementing cloud-based and on-premises customer experience tools that enable clients to develop customer engagement strategies. TTEC Engage focuses on delivering sales and marketing solutions to help clients boost their revenue as well as on managing customer's front-to-back office processes to optimize the customer experience. TTEC Engage contributes the vast majority of the company's revenue, and its revenues are derived from the United States and Canada, followed by Philippines, Asia-Pacific and India.

About UNCY Unicycive Therapeutics Inc.

Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's manufactures drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury. Company's pipeline comprised of two product candidates: Oxylanthanum Carbonate and UNI-494.

Share on Social Networks: